| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.37 | 2e-07 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.007 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.009 |